Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ICON Central Laboratories Launches New Facility In Singapore To Meet Spiking Demand

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - ICON Central Laboratories recently moved its operation in Singapore to a larger facility to keep pace with a sharp rise in demand for its lab services across Asia

You may also be interested in...



ICON Goes Local As China CRO Market Heats Up

Acquisition of BeijingWits will boost ICON’s clinical trial capabilities in China and the Asia Pacific region.

ICON Opens New Asian Offices To Keep Pace With Growing Demand For More Trials In Emerging Markets

BEIJING - Ireland-headquartered global contract research organization ICON is expanding its presence in the Asia Pacific region due to the growing attractiveness of conducting clinical trials in the region

ICON Opens New Asian Offices To Keep Pace With Growing Demand For More Trials In Emerging Markets

BEIJING - Ireland-headquartered global contract research organization ICON is expanding its presence in the Asia Pacific region due to the growing attractiveness of conducting clinical trials in the region

UsernamePublicRestriction

Register

PS140995

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel